1. Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): A new dimension in immunotherapy

   • G. Schwab
   • T. Hecht

   Original Article Pages: 1 - 9

2. A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia

   • S. Pavlovsky
   • J. Gonzalez Llaven
   • F. José de Diego

   Original Article Pages: 11 - 15

3. High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis

   • J. L. Gala
   • C. Vermylen
   • P. Martiat

   Original Article Pages: 17 - 24

4. Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop

   • R. Burger
   • J. Wendler
   • M. Gramatzki

   Original Article Pages: 25 - 31

5. Hematologic aspects of end-stage renal failure

   • P. Zachée
   • J. Vermylen
   • M. A. Boogaerts

   Original Article Pages: 33 - 40

6. Hyperphosphatemia in multiple myeloma

   • S. Oren
   • A. Feldman
   • G. Lugassy

   Case Report Pages: 41 - 43

7. Role of protein kinases in antitumor drug resistance

   • H. Grunicke
   • J. Hofmann
   • F. überall

   First Workshop of CSG-CR Pages: S1 - S6

8. DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells

   • P. J. Smith
   • C. Rackstraw
   • F. Cotter

   First Workshop of CSG-CR Pages: S7 - S11

9. Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding

   • F. Gieseler
   • H. Biersack
   • V. Nüßler

   First Workshop of CSG-CR Pages: S13 - S17

10. Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias

    • V. Gekeler
    • J. Beck
    • D. Niethammer

    First Workshop of CSG-CR Pages: S19 - S24

11. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal

    • V. Nüssler
    • R. Pelka-Fleischer
    • W. Wilmanns

    First Workshop of CSG-CR Pages: S25 - S29

12. Cellular drug resistance in childhood leukemia

    • A. J. P. Veerman
    • G. J. L. Kaspers
    • R. Pieters

    First Workshop of CSG-CR Pages: S31 - S34